Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Taps Prisma Biotech to Market, Sell CustomArrays in Taiwan, China

NEW YORK, April 28 (GenomeWeb News) - CombiMatrix today said that Prisma Biotech will promote and sell its products in Taiwan, China, and "various" other countries.

 

The Acacia unit also said that Prisma "has the ability to synthesize content onto CombiMatrix CustomArrays and to sell those arrays to end customers."

 

Financial terms of the agreement were not disclosed.

 

CombiMatrix is currently establishing manufacturing and distribution relationships with regional companies to "enable them to manufacture arrays onsite for their local markets," the company said. "Such relationships benefit CombiMatrix by expanding the commercial market for its products without having to build additional infrastructure."

 

Besides selling its synthesizers to these partners, CombiMatrix said it "will continue to sell blank CustomArrays, reagents, additional synthesizers, and equipment to the partner for its local customers."

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.